DXR Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:05):

Stats
Šios dienos apimtis	105.00
Vidutinė apimtis	2 743.00
Rinkos kapitalizacija	45.98M
EPS	$0 ( 2024-03-13 )
Kita pelno data	( $0 ) 2024-07-10
Last Dividend	$0.0300 ( 2018-01-05 )
Next Dividend	$0 ( N/A )
P/E	69.36
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-27	Michel Robert J	Buy	750	Daxor Common Stock
2024-03-04	Feuer Edward	Buy	1 000	Daxor Common Stock
2023-12-06	Michel Robert J	Buy	120	Daxor Common Stock
2023-12-01	Michel Robert J	Buy	180	Daxor Common Stock
2023-12-01	Feldschuh Michael Richard	Buy	800	Daxor Common Stock

INSIDER POWER
56.73
Last 97 transactions
Buy: 668 992 \| Sell: 434 444

Daxor Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Daxor Corp Finansinės ataskaitos

Annual	2023
Pajamos:	$34.59M
Bruto pelnas:	$34.41M (99.49 %)
EPS:	$0.0606

FY	2023
Pajamos:	$34.59M
Bruto pelnas:	$34.41M (99.49 %)
EPS:	$0.0606

FY	2022
Pajamos:	$6.31M
Bruto pelnas:	$5.22M (82.77 %)
EPS:	$1.270

FY	2021
Pajamos:	$5.82M
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$1.170

Financial Reports:

No articles found.

Daxor Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Daxor Corp Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 2.66 - low (50.00%) | Divividend Growth Potential Score: 0.477 - No dividend growth expected in the near future

Information

First Dividend	$0.500	1997-04-28
Last Dividend	$0.0300	2018-01-05
Next Dividend	$0	N/A
Payout Date	2018-01-12
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	$5.11	--
Avg. Dividend % Per Year	0.00%	--
Score	1.17	--
Div. Sustainability Score	2.66
Div.Growth Potential Score	0.477
Div. Directional Score	1.566	--

Next Divdend (Est)
(2024-07-15)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.17

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for AMEX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PFIX	Ex Dividend Knight	2023-08-28	Monthly	0.00%
CVR	Ex Dividend Junior	2023-09-01	Quarterly	0.00%
HNW	Ex Dividend King	2023-08-17	Monthly	0.00%
NML	Ex Dividend Knight	2023-09-14	Monthly	0.00%
CIX	Ex Dividend King	2023-08-31	Quarterly	0.00%
GGN	Ex Dividend Knight	2023-10-16	Monthly	0.00%
NBH	Ex Dividend Knight	2023-09-28	Monthly	0.00%
UTG	Ex Dividend Knight	2023-08-17	Monthly	0.00%
BOAT	Ex Dividend Junior	2023-06-27	Quarterly	0.00%
EVV	Ex Dividend King	2023-09-08	Monthly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0121	1.500	9.76	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0121	1.200	9.60	10.00	[0 - 0.3]
returnOnEquityTTM	0.0131	1.500	-0.966	-1.449	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.251	0.800	-3.74	-3.00	[1 - 3]
quickRatioTTM	0.138	0.800	-3.90	-3.12	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0.0217	-1.500	9.64	-10.00	[0 - 0.6]
interestCoverageTTM	-6.56	1.000	-3.54	-3.54	[3 - 30]
operatingCashFlowPerShareTTM	-1.712	2.00	-0.571	-1.141	[0 - 30]
freeCashFlowPerShareTTM	-1.712	2.00	-0.856	-1.712	[0 - 20]
debtEquityRatioTTM	0.0222	-1.500	9.91	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.987	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.00928	1.000	-2.19	-2.19	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-10.89	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.994	0.800	6.70	5.36	[0.5 - 2]
Total Score				2.66

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	112.81	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0131	2.50	-0.621	-1.449	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.712	2.00	-0.571	-1.712	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.712	2.00	-0.571	-1.141	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.297	1.500	4.69	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.237	1.000	-8.43	0	[0.1 - 0.5]
Total Score				0.477

Daxor Corp

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.